HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma-Reference-Cited by-同舟云学术

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

Published:2019-01-08 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Plum Patrick Sven,Gebauer Florian,Krämer Max,Alakus Hakan,Berlth Felix,Chon Seung-Hun,Schiffmann Lars,Zander Thomas,Büttner Reinhard,Hölscher Arnulf Heinrich,Bruns Christiane Josephine,Quaas Alexander,Loeser Heike

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-5242-4.pdf

Reference44 articles.

1. Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112(8):1247–1255. https://www.ncbi.nlm.nih.gov/pubmed/?term=28585555 .

2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–2252. https://www.ncbi.nlm.nih.gov/pubmed/?term=14657432 .

3. Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. 390, Lancet. 2017. p. 2383–2396. https://www.ncbi.nlm.nih.gov/pubmed/?term=28648400 .

4. Dai T, Shah MA. Chemoradiation in oesophageal cancer. Best Pract Res Clin Gastroenterol. 2015;29(1):193–209. https://www.ncbi.nlm.nih.gov/pubmed/?term=25743466 .

5. van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, Henegouwen MIVB, Wijnhoven BPL, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study;Translational Oncology;2024-11

2. Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma;Pharmacological Research;2024-09

3. Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank;Journal of Cancer Research and Clinical Oncology;2024-08-24

4. Analyzing the Impact of Oncological Data at Different Time Points and Tumor Biomarkers on Artificial Intelligence Predictions for Five-Year Survival in Esophageal Cancer;Machine Learning and Knowledge Extraction;2024-03-19

5. HER2 Prognostic Significance and Therapeutic Implications in Gastric Cardia Adenocarcinoma: Insights from Multi-Omics Profiling;2024-03-06